Click here to access insights and external resources collected by Nelson Mullins on the first 100 days of the new presidential administration and Congress. These articles and fact sheets are non-partisan in nature and address the impact of each on various industries and client sectors.
Click here to access our extensive COVID-19 resources that address a wide variety of topics in general and by industry.
January 14, 2021
Winston-Salem Partner Gray Wilson Authors N.C. Civil Procedure Fourth Editionour team can guide you each step of the way.
Our team brings you real world, practical perspectives and includes
Our clients span industry sectors and are both large and small, ranging from entrepreneurs and start-ups to established household names. Clients we've served include medical and research institutions, global specialty chemical companies, U.S. financial institutions, and clients in a range of business areas, including
Clients who do business on a worldwide basis have entrusted us to maintain a large portfolio of domestic and international patent application filings. In addition to our work representing clients across the United States and around the globe, we bring to you a network of patent legal contacts around the world. Nelson Mullins also brings to you an IP legal team with experience representing clients in transactional proceedings and in IP litigation in the United States, Europe, Asia, and South America.
Our experience in the area of antibody-based therapeutics and related platform technologies includes providing client services to over 30 leading companies in the field. More particular experience areas include: Antibody formats (Humanized, chimeric and fully human antibodies, Alternative scaffolds, Glycoforms, Antibody drug conjugates, Bispecific and multispecific formats), Antisense and RNAi, Discovery technologies (Phage and yeast display, Affinity maturation, Acellular expression, Transgenic production), FDA labelling/clinical trials, Gene Therapy, Green technologies, Metabolites, Nutraceuticals, Personalized medicine/ biomarkers, Prodrugs, Recombinant proteins, Salts/polymorphic crystal forms, Sequencing technologies, and Small molecules.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Our team brings you real world, practical perspectives and includes
Our clients span industry sectors and are both large and small, ranging from entrepreneurs and start-ups to established household names. Clients we've served include medical and research institutions, global specialty chemical companies, U.S. financial institutions, and clients in a range of business areas, including
Clients who do business on a worldwide basis have entrusted us to maintain a large portfolio of domestic and international patent application filings. In addition to our work representing clients across the United States and around the globe, we bring to you a network of patent legal contacts around the world. Nelson Mullins also brings to you an IP legal team with experience representing clients in transactional proceedings and in IP litigation in the United States, Europe, Asia, and South America.
Our experience in the area of antibody-based therapeutics and related platform technologies includes providing client services to over 30 leading companies in the field. More particular experience areas include: Antibody formats (Humanized, chimeric and fully human antibodies, Alternative scaffolds, Glycoforms, Antibody drug conjugates, Bispecific and multispecific formats), Antisense and RNAi, Discovery technologies (Phage and yeast display, Affinity maturation, Acellular expression, Transgenic production), FDA labelling/clinical trials, Gene Therapy, Green technologies, Metabolites, Nutraceuticals, Personalized medicine/ biomarkers, Prodrugs, Recombinant proteins, Salts/polymorphic crystal forms, Sequencing technologies, and Small molecules.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
We use cookies to improve functionality and performance of our website and to provide you with the best possible browsing experience. These cookies include those which are strictly necessary for website operation, as well as those which are used for functionality and performance purposes.
For more information on how our Sites use cookies, click here to view our Cookie Policy.